FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 27 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $22,000 | -76.8% | 3,068 | -79.8% | 0.00% | – |
Q1 2021 | $95,000 | -22.8% | 15,201 | -8.0% | 0.00% | – |
Q4 2020 | $123,000 | +66.2% | 16,527 | +35.2% | 0.00% | – |
Q3 2020 | $74,000 | -20.4% | 12,225 | +9.4% | 0.00% | – |
Q2 2020 | $93,000 | +933.3% | 11,174 | +702.2% | 0.00% | – |
Q4 2019 | $9,000 | -18.2% | 1,393 | -50.4% | 0.00% | – |
Q2 2019 | $11,000 | -95.0% | 2,810 | -93.9% | 0.00% | – |
Q1 2019 | $222,000 | +133.7% | 46,141 | +206.2% | 0.00% | – |
Q4 2018 | $95,000 | -76.5% | 15,068 | -69.6% | 0.00% | – |
Q3 2018 | $405,000 | -30.3% | 49,512 | -11.3% | 0.00% | – |
Q2 2018 | $581,000 | +67.0% | 55,813 | +93.7% | 0.00% | – |
Q1 2018 | $348,000 | +5700.0% | 28,811 | +4670.0% | 0.00% | – |
Q4 2017 | $6,000 | – | 604 | +11980.0% | 0.00% | – |
Q3 2017 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 960,000 | $8,016,000 | 7.40% |
Sonic Fund II, L.P. | 1,634,689 | $13,650,000 | 6.79% |
Southpoint Capital Advisors LP | 4,077,214 | $34,045,000 | 0.83% |
683 Capital Management, LLC | 1,110,000 | $9,269,000 | 0.74% |
Opaleye Management Inc. | 171,000 | $1,428,000 | 0.29% |
Avoro Capital Advisors LLC | 1,670,000 | $13,945,000 | 0.28% |
Eventide Asset Management | 1,120,000 | $9,352,000 | 0.20% |
CADENCE CAPITAL MANAGEMENT LLC | 153,556 | $1,282,000 | 0.19% |
Hartford Financial Management Inc. | 49,548 | $414,000 | 0.13% |
Granahan Investment Management | 245,377 | $2,049,000 | 0.07% |